Awakn Life Sciences (TSE:AWKN) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Awakn Life Sciences Corp., a biotechnology company focused on addiction therapeutics, has secured an unsecured credit facility of up to $535,000 to support its ongoing research and development projects. This financial move helps the company maintain its momentum in reaching new milestones, particularly in its lead programs AWKN-001 and AWKN-002 targeting mental health disorders.
For further insights into TSE:AWKN stock, check out TipRanks’ Stock Analysis page.
